Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of antidepressant efficacy of oral ketamine treatment
2016-002068-14Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in major depressive disorder (MDD) and bipolar disorder (BD) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Montgomery-Asberg Depression Rating Scale (MADRS). Started Nov 2016; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2016-002068-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002068-14.